PharmaDrug Inc unveils plans for first-in-human clinical study with its lead drug candidate PD-001 in esophageal cancer

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) revealed that it intends to pursue a first-in-human study of its lead drug candidate cepharanthine-2HCL (PD-001) for...

Related Keywords

Australia ,Japan ,Toronto ,Ontario ,Canada ,Daniel Cohen ,Australia Therapeutic Goods Administration ,Pharmadrug Inc ,Australia Research ,Drug Administration ,Genvion Corporation ,Therapeutic Goods Administration ,Investigational New Drug ,Current Good Manufacturing Practice ,